Stemline Therapeutics Inc (NASDAQ:STML)

15.63
Delayed Data
As of Mar 02
 +0.44 / +2.90%
Today’s Change
10.50
Today|||52-Week Range
27.17
-8.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues71.0K71.0K71.4K71.4K
 
 
 
 
 
Depreciation And Amortization38.3K38.3K38.3K38.3K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses7.9M9.1M6.1M6.9M
 
 
 
 
 
Research And Development5.6M7.1M4.1M5.0M
 
 
 
 
 
Total Operating Expenses8.0M9.1M6.1M7.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.9M-9.0M-6.0M-6.9M
 
 
 
 
 
Extraordinary Credit60.8K0.00----
 
 
Interest Expense On Debt11.8K--0.000.00
 
 
Other Expenses189.2K-7.9K-10.5K-8.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.7M-9.0M-6.0M-6.9M
 
 
 
 
 
Net Income-7.7M-9.0M-6.0M-6.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.8M12.9M12.9M13.0M
 
 
 
 
 
Shares To Calculate EPS Diluted12.8M12.9M12.9M13.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.60-$0.70-$0.47-$0.53
 
 
 
 
 
EPS Diluted-$0.60-$0.70-$0.47-$0.53
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account